Cell Therapy Catapult Limited
Other professional, scientific and technical activities n.e.c. · London
ActiveUnited KingdomIncorporated 2012Private, limited by guarantee, no share capital
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No processed account filings
No processed accounts are available in our records.
Registered details
07964711- Status
- Active
- Type
- Private, limited by guarantee, no share capital
- Incorporated
- 2012-02-24
- Jurisdiction
- —
- Registered office
- 12TH FLOOR, TOWER WING B, LONDON, SE1 9RT
Classification
1 SIC codes74909
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
103 matched grantsLir Therapeutics LimitedLead
Innovate UK · Centres · 2026-03-01 – 2026-03-31
£500,000
awarded
EcoSynth: Enabling Reliable Data CaptureInnovate UK · Grant for R&D · 2026-02-01 – 2026-08-31 · with 1 other participant£0awarded
EcoSynth: Enabling Reliable Data Capture
Innovate UK · Grant for R&D · 2026-02-01 – 2026-08-31 · with 1 other participant
£0
awarded
Cell Therapy Catapult Limited£0
Stratosvir LimitedLead
Innovate UK · Centres · 2026-01-01 – 2026-03-31
£500,000
awarded
Korecyte Holding LimitedLead
Innovate UK · Centres · 2026-01-01 – 2026-03-31
£500,000
awarded
Smart Personalised Healthcare: Evaluation, Response and Engagement (SPHERE)LeadInnovate UK · Centres · 2025-10-01 – 2026-03-31 · with 3 other participants£249,968awarded
Smart Personalised Healthcare: Evaluation, Response and Engagement (SPHERE)Lead
Innovate UK · Centres · 2025-10-01 – 2026-03-31 · with 3 other participants
£249,968
awarded
Cell Therapy Catapult Limitedlead£249,968
Realising Full Robotic Automation for Industrial Advanced Therapy Manufacturing; Expanding Constellation Functionality at the Catapult Digital and Automation Test Beds.LiveInnovate UK · Collaborative R&D · 2025-07-01 – 2027-02-28 · with 2 other participants£298,975awarded
Realising Full Robotic Automation for Industrial Advanced Therapy Manufacturing; Expanding Constellation Functionality at the Catapult Digital and Automation Test Beds.Live
Innovate UK · Collaborative R&D · 2025-07-01 – 2027-02-28 · with 2 other participants
£298,975
awarded
Cell Therapy Catapult Limited£298,975
Translating Angicyte® from allogeneic to autologous – a robust development process for a low-cost vascular therapy for personalised medicineInnovate UK · Collaborative R&D · 2025-06-01 – 2026-08-31 · with 2 other participants£89,606awarded
Translating Angicyte® from allogeneic to autologous – a robust development process for a low-cost vascular therapy for personalised medicine
Innovate UK · Collaborative R&D · 2025-06-01 – 2026-08-31 · with 2 other participants
£89,606
awarded
The UK Regulatory Innovation Network for Advanced TherapiesLeadInnovate UK · Collaborative R&D · 2025-02-01 – 2026-03-31 · with 1 other participant£720,510awarded
The UK Regulatory Innovation Network for Advanced TherapiesLead
Innovate UK · Collaborative R&D · 2025-02-01 – 2026-03-31 · with 1 other participant
£720,510
awarded
Cell Therapy Catapult Limitedlead£720,510
Building a Sustainable Platform for rAAV Gene Therapy ManufacturingLiveInnovate UK · Collaborative R&D · 2025-02-01 – 2027-03-31 · with 1 other participant£206,298awarded
Building a Sustainable Platform for rAAV Gene Therapy ManufacturingLive
Innovate UK · Collaborative R&D · 2025-02-01 – 2027-03-31 · with 1 other participant
£206,298
awarded
Cell Therapy Catapult Limited£206,298
EcoCAR: Sustainable CAR T cell manufactureInnovate UK · Feasibility Studies · 2025-01-01 – 2025-06-30 · with 3 other participants£13,632awarded
EcoCAR: Sustainable CAR T cell manufacture
Innovate UK · Feasibility Studies · 2025-01-01 – 2025-06-30 · with 3 other participants
£13,632
awarded
Cell Therapy Catapult Limited£13,632
Preclinical development of a systemically deliverable oncolytic Vaccinia virus (VacV002-TD-IL10D-ENPP1) for treatment of metastatic colorectal cancer.Innovate UK · Collaborative R&D · 2024-09-01 – 2026-07-31 · with 1 other participant£139,164awarded
Preclinical development of a systemically deliverable oncolytic Vaccinia virus (VacV002-TD-IL10D-ENPP1) for treatment of metastatic colorectal cancer.
Innovate UK · Collaborative R&D · 2024-09-01 – 2026-07-31 · with 1 other participant
£139,164
awarded
Cell Therapy Catapult Limited£139,164
Advancing Angicyte - A novel vasoreparative cell therapy for revascularisation of Diabetic Foot UlcersInnovate UK · Collaborative R&D · 2024-08-01 – 2026-06-30 · with 2 other participants£228,696awarded
Advancing Angicyte - A novel vasoreparative cell therapy for revascularisation of Diabetic Foot Ulcers
Innovate UK · Collaborative R&D · 2024-08-01 – 2026-06-30 · with 2 other participants
£228,696
awarded
Scottish National Blood Transfusion Service£749,727
Cell Therapy Catapult Limited£228,696
Industry Skills AcceleratorLeadInnovate UK · Collaborative R&D · 2024-08-01 – 2026-03-31 · with 2 other participants£290,115awarded
Industry Skills AcceleratorLead
Innovate UK · Collaborative R&D · 2024-08-01 – 2026-03-31 · with 2 other participants
£290,115
awarded
Cell Therapy Catapult Limitedlead£290,115
AAV Formulation Consortium - Improving AAV stability through optimised formulations and development of an analytical toolbox for stability characterisationLeadInnovate UK · Collaborative R&D · 2024-05-01 – 2026-03-31 · with 3 other participants£510,148awarded
AAV Formulation Consortium - Improving AAV stability through optimised formulations and development of an analytical toolbox for stability characterisationLead
Innovate UK · Collaborative R&D · 2024-05-01 – 2026-03-31 · with 3 other participants
£510,148
awarded
Cell Therapy Catapult Limitedlead£510,148
AAV Production Process Intensification using Perfusion Bioreactor TechnologyInnovate UK · Collaborative R&D · 2024-05-01 – 2026-04-30 · with 2 other participants£686,692awarded
AAV Production Process Intensification using Perfusion Bioreactor Technology
Innovate UK · Collaborative R&D · 2024-05-01 – 2026-04-30 · with 2 other participants
£686,692
awarded
Cell Therapy Catapult Limited£686,692
Utilising dbDNA for enhanced AAV Manufacture, Performance & Cost: Enabling the Next Generation of UK-based Advanced Therapies InnovatorsLeadInnovate UK · Collaborative R&D · 2024-03-01 – 2025-11-30 · with 2 other participants£610,571awarded
Utilising dbDNA for enhanced AAV Manufacture, Performance & Cost: Enabling the Next Generation of UK-based Advanced Therapies InnovatorsLead
Innovate UK · Collaborative R&D · 2024-03-01 – 2025-11-30 · with 2 other participants
£610,571
awarded
Cell Therapy Catapult Limitedlead£610,571
A Flexible Molecular Platform for Agile and Scalable Cell PurificationInnovate UK · Collaborative R&D · 2024-03-01 – 2025-03-31 · with 1 other participant£145,146awarded
A Flexible Molecular Platform for Agile and Scalable Cell Purification
Innovate UK · Collaborative R&D · 2024-03-01 – 2025-03-31 · with 1 other participant
£145,146
awarded
Cell Therapy Catapult Limited£145,146
The UK Regulatory Innovation Network for Advanced TherapiesLeadInnovate UK · Collaborative R&D · 2024-03-01 – 2024-08-31 · with 1 other participant£24,475awarded
The UK Regulatory Innovation Network for Advanced TherapiesLead
Innovate UK · Collaborative R&D · 2024-03-01 – 2024-08-31 · with 1 other participant
£24,475
awarded
Cell Therapy Catapult Limitedlead£24,475
Speed-CELL: Accelerating Cell Therapy Release for Rapid Clinical DeploymentInnovate UK · Collaborative R&D · 2024-03-01 – 2024-08-31 · with 4 other participants£0awarded
Speed-CELL: Accelerating Cell Therapy Release for Rapid Clinical Deployment
Innovate UK · Collaborative R&D · 2024-03-01 – 2024-08-31 · with 4 other participants
£0
awarded
Cell Therapy Catapult Limited£0
NHS Blood and Transplant£0
Next-generation automation and PAT implementation for QbD and enhanced approaches for cell and gene therapyLead
Innovate UK · Collaborative R&D · 2024-02-01 – 2026-07-31
£398,677
awarded
Grant Funding Agreement In Relation To The Advanced Therapy Treatment Centre Network Coordinated By Cell Therapy Catapult LimitedLeadLive
Innovate UK · Centres · 2024-02-01 – 2028-03-31
£17,673,757
awarded
Development of a Novel Gene Therapy for Neurodegenerative DiseasesInnovate UK · Collaborative R&D · 2023-10-01 – 2025-06-30 · with 1 other participant£163,395awarded
Development of a Novel Gene Therapy for Neurodegenerative Diseases
Innovate UK · Collaborative R&D · 2023-10-01 – 2025-06-30 · with 1 other participant
£163,395
awarded
Cell Therapy Catapult Limited£163,395
Implementation & digitalisation of Process Analytical Technologies to increase productivity, support rapid release and reduce costs of goods in industrial scale Cell & Gene Therapy (CGT) manufacturingInnovate UK · Collaborative R&D · 2023-06-01 – 2025-05-31 · with 1 other participant£440,302awarded
Implementation & digitalisation of Process Analytical Technologies to increase productivity, support rapid release and reduce costs of goods in industrial scale Cell & Gene Therapy (CGT) manufacturing
Innovate UK · Collaborative R&D · 2023-06-01 – 2025-05-31 · with 1 other participant
£440,302
awarded
Cell Therapy Catapult Limited£440,302
Advanced process control of AAV manufacture: digitalisation, PAT and automation to improve productivity, quality and consistencyInnovate UK · Collaborative R&D · 2023-06-01 – 2025-05-31 · with 2 other participants£799,380awarded
Advanced process control of AAV manufacture: digitalisation, PAT and automation to improve productivity, quality and consistency
Innovate UK · Collaborative R&D · 2023-06-01 – 2025-05-31 · with 2 other participants
£799,380
awarded
A software platform enabling rapidly customisable extended reality (XR) training and manufacturing assistance toolsInnovate UK · Collaborative R&D · 2023-05-01 – 2024-10-31 · with 2 other participants£119,752awarded
A software platform enabling rapidly customisable extended reality (XR) training and manufacturing assistance tools
Innovate UK · Collaborative R&D · 2023-05-01 – 2024-10-31 · with 2 other participants
£119,752
awarded
Enhanced NK cell function and expansion for immunotherapyInnovate UK · Collaborative R&D · 2023-04-01 – 2025-03-31 · with 1 other participant£664,782awarded
Enhanced NK cell function and expansion for immunotherapy
Innovate UK · Collaborative R&D · 2023-04-01 – 2025-03-31 · with 1 other participant
£664,782
awarded
Cell Therapy Catapult Limited£664,782
Cell And Gene Therapy Catapult Core Delivery ProgrammeLeadLive
Innovate UK · Centres · 2023-04-01 – 2028-03-31
£86,888,198
awarded
Engineered Protein Polymers for Industrial Cell Culture (EPPICC)Innovate UK · Investment Accelerator · 2023-02-01 – 2024-03-31 · with 1 other participant£58,268awarded
Engineered Protein Polymers for Industrial Cell Culture (EPPICC)
Innovate UK · Investment Accelerator · 2023-02-01 – 2024-03-31 · with 1 other participant
£58,268
awarded
Marra Biolead£239,118
Cell Therapy Catapult Limited£58,268
Smart MAnufactuRing for Autologous Cell ThERapies enabled by innovative biomonitoring technologies and advanced process control (SMARTER)Lead
Innovate UK · EU-Funded · 2022-09-01 – 2026-02-28
£1,204,571
awarded
Smart MAnufactuRing for Autologous Cell ThERapies enabled by innovative biomonitoring technologies and advanced process control (SMARTER)
Horizon Europe Guarantee · EU-Funded · 2022-08-31 – 2026-02-28
£1,204,570
whole project
Smart MAnufactuRing for Autologous Cell ThERapies enabled by innovative biomonitoring technologies and advanced process control (SMARTER)Lead
Horizon Europe Guarantee · EU-Funded · 2022-08-31 – 2026-02-28
£1,204,570
whole project
Development of an integrated and scalable platform process for the robust manufacture of allogeneic iPSC immunotherapiesInnovate UK · Collaborative R&D · 2022-07-01 – 2024-10-31 · with 2 other participants£341,311awarded
Development of an integrated and scalable platform process for the robust manufacture of allogeneic iPSC immunotherapies
Innovate UK · Collaborative R&D · 2022-07-01 – 2024-10-31 · with 2 other participants
£341,311
awarded
Development of an in-body cell therapy treatment using nanoparticlesInnovate UK · Collaborative R&D · 2022-06-01 – 2024-03-31 · with 2 other participants£107,826awarded
Development of an in-body cell therapy treatment using nanoparticles
Innovate UK · Collaborative R&D · 2022-06-01 – 2024-03-31 · with 2 other participants
£107,826
awarded
Cell Therapy Catapult Limited£107,826
Development of Angicyte, a new vasoreparative cell therapy for chronic non healing wounds (“Angicyte_BMC”)Innovate UK · Collaborative R&D · 2022-05-01 – 2024-04-30 · with 3 other participants£111,138awarded
Development of Angicyte, a new vasoreparative cell therapy for chronic non healing wounds (“Angicyte_BMC”)
Innovate UK · Collaborative R&D · 2022-05-01 – 2024-04-30 · with 3 other participants
£111,138
awarded
Queen's University of Belfast£223,523
Scottish National Blood Transfusion Service£122,435
Cell Therapy Catapult Limited£111,138
Preclinical development of a first in class stem cell therapy for hearing lossInnovate UK · Collaborative R&D · 2021-04-01 – 2023-05-31 · with 1 other participant£1,028,557awarded
Preclinical development of a first in class stem cell therapy for hearing loss
Innovate UK · Collaborative R&D · 2021-04-01 – 2023-05-31 · with 1 other participant
£1,028,557
awarded
Cell Therapy Catapult Limited£1,028,557
ATMP apprenticeship runway fundingLead
Innovate UK · Collaborative R&D · 2021-04-01 – 2022-03-31
£500,000
awarded
ATMP apprenticeship runway fundingLead
ISCF · Collaborative R&D · 2021-03-31 – 2022-03-30
£500,000
whole project
ATMP apprenticeship runway funding
ISCF · Collaborative R&D · 2021-03-31 – 2022-03-30
£500,000
whole project
Accelerating analytics for gene therapy using enhanced mass photometryInnovate UK · Study · 2020-10-01 – 2021-09-30 · with 1 other participant£107,564awarded
Accelerating analytics for gene therapy using enhanced mass photometry
Innovate UK · Study · 2020-10-01 – 2021-09-30 · with 1 other participant
£107,564
awarded
Cell Therapy Catapult Limited£107,564
CcattsLead
Innovate UK · Centres · 2020-09-01 – 2023-03-31
£4,700,000
awarded
Large-scale microfluidic bioprocessing platform for cell and gene therapy manufacturingInnovate UK · Study · 2020-06-01 – 2022-03-31 · with 2 other participants£162,261awarded
Large-scale microfluidic bioprocessing platform for cell and gene therapy manufacturing
Innovate UK · Study · 2020-06-01 – 2022-03-31 · with 2 other participants
£162,261
awarded
Cell Therapy Catapult Limited£162,261
GFA in relation to the Acquisition, Development and Operation of the Cell and Gene Therapy Catapult Manufacturing Innovation CentreLeadLive
Innovate UK · Centres · 2020-06-01 – 2027-03-31
£127,500,000
awarded
Assessing PAT for process monitoring and modification of viral vector manufacture processingISCF · CR&D Bilateral · 2020-03-01 – 2021-11-30 · with 3 other participants£590,432whole project
Assessing PAT for process monitoring and modification of viral vector manufacture processing
ISCF · CR&D Bilateral · 2020-03-01 – 2021-11-30 · with 3 other participants
£590,432
whole project
Pharmaron Biologics (UK) LtdleadCell Therapy Catapult LimitedCell Therapy Catapult Services LimitedNpl Management Limited
Assessing PAT for process monitoring and modification of viral vector manufacture processingInnovate UK · CR&D Bilateral · 2020-03-01 – 2021-11-30 · with 3 other participants£280,316awarded
Assessing PAT for process monitoring and modification of viral vector manufacture processing
Innovate UK · CR&D Bilateral · 2020-03-01 – 2021-11-30 · with 3 other participants
£280,316
awarded
Cell Therapy Catapult Limited£280,316
A novel vascular stem cell product ANGICYTE for regenerative medicineInnovate UK · Study · 2020-02-01 – 2021-12-31 · with 1 other participant£12,709awarded
A novel vascular stem cell product ANGICYTE for regenerative medicine
Innovate UK · Study · 2020-02-01 – 2021-12-31 · with 1 other participant
£12,709
awarded
Cell Therapy Catapult Limited£12,709
Extension of shelf-life for cell therapies at room temperatureInnovate UK · Feasibility Studies · 2019-09-01 – 2021-05-31 · with 1 other participant£132,278awarded
Extension of shelf-life for cell therapies at room temperature
Innovate UK · Feasibility Studies · 2019-09-01 – 2021-05-31 · with 1 other participant
£132,278
awarded
Cell Therapy Catapult Limited£132,278
Generation of human-sized bioengineered bile ductsInnovate UK · Feasibility Studies · 2019-02-01 – 2020-01-31 · with 1 other participant£75,179awarded
Generation of human-sized bioengineered bile ducts
Innovate UK · Feasibility Studies · 2019-02-01 – 2020-01-31 · with 1 other participant
£75,179
awarded
Cell Therapy Catapult Limited£75,179
Patient-reported outcomes assessment to support accelerated access to advanced cell and gene therapies: PROmicsInnovate UK · Collaborative R&D · 2018-12-01 – 2022-03-31 · with 5 other participants£63,820awarded
Patient-reported outcomes assessment to support accelerated access to advanced cell and gene therapies: PROmics
Innovate UK · Collaborative R&D · 2018-12-01 – 2022-03-31 · with 5 other participants
£63,820
awarded
University Hospitals Birmingham NHS Foundation Trustlead£105,405
Cell Therapy Catapult Limited£63,820
The Christie NHS Foundation Trust£25,976
The Newcastle upon Tyne Hospitals NHS Foundation Trust£4,988
Patient-reported outcomes assessment to support accelerated access to advanced cell and gene therapies: PROmicsISCF · Collaborative R&D · 2018-12-01 – 2022-03-30 · with 5 other participants£1,308,606whole project
Patient-reported outcomes assessment to support accelerated access to advanced cell and gene therapies: PROmics
ISCF · Collaborative R&D · 2018-12-01 – 2022-03-30 · with 5 other participants
£1,308,606
whole project
University Hospitals Birmingham NHS Foundation TrustleadCell Therapy Catapult LimitedDignio LimitedThe Christie NHS Foundation TrustThe Newcastle Upon Tyne Hospitals NHS Foundation TrustUniversity Of Birmingham
Autologous Stem-Cell Based Tissue Engineered Treatment for Bronchopleural FistulaInnovate UK · Collaborative R&D · 2018-11-01 – 2022-03-31 · with 2 other participants£760,011awarded
Autologous Stem-Cell Based Tissue Engineered Treatment for Bronchopleural Fistula
Innovate UK · Collaborative R&D · 2018-11-01 – 2022-03-31 · with 2 other participants
£760,011
awarded
Cell Therapy Catapult Limited£760,011
Royal Papworth Hospital NHS Foundation Trust£389,882
Development of an Innovative Supply Chain Model to Expedite Delivery of Viral Vector ATIMPs to Clinical TrialsISCF · Collaborative R&D · 2018-11-01 – 2021-10-30 · with 2 other participants£949,548whole project
Development of an Innovative Supply Chain Model to Expedite Delivery of Viral Vector ATIMPs to Clinical Trials
ISCF · Collaborative R&D · 2018-11-01 – 2021-10-30 · with 2 other participants
£949,548
whole project
Freeline Therapeutics LimitedleadCell Therapy Catapult LimitedSymbiosis Pharmaceutical Services Limited
Development of an Innovative Supply Chain Model to Expedite Delivery of Viral Vector ATIMPs to Clinical TrialsInnovate UK · Collaborative R&D · 2018-11-01 – 2021-10-31 · with 2 other participants£398,457awarded
Development of an Innovative Supply Chain Model to Expedite Delivery of Viral Vector ATIMPs to Clinical Trials
Innovate UK · Collaborative R&D · 2018-11-01 – 2021-10-31 · with 2 other participants
£398,457
awarded
Cell Therapy Catapult Limited£398,457
Purification of Adeno-Associated Virus (AAV) by continuous ChromatographyISCF · Feasibility Studies · 2018-11-01 – 2021-04-29 · with 2 other participants£1,034,337whole project
Purification of Adeno-Associated Virus (AAV) by continuous Chromatography
ISCF · Feasibility Studies · 2018-11-01 – 2021-04-29 · with 2 other participants
£1,034,337
whole project
Purification of Adeno-Associated Virus (AAV) by continuous ChromatographyInnovate UK · Feasibility Studies · 2018-11-01 – 2021-04-30 · with 2 other participants£449,450awarded
Purification of Adeno-Associated Virus (AAV) by continuous Chromatography
Innovate UK · Feasibility Studies · 2018-11-01 – 2021-04-30 · with 2 other participants
£449,450
awarded
RFID to enable ATMP Manufacturing, Cryogenic Supply Chain Scale-Up and Productivity GainsInnovate UK · Collaborative R&D · 2018-10-01 – 2022-03-31 · with 4 other participants£153,505awarded
RFID to enable ATMP Manufacturing, Cryogenic Supply Chain Scale-Up and Productivity Gains
Innovate UK · Collaborative R&D · 2018-10-01 – 2022-03-31 · with 4 other participants
£153,505
awarded
Cranfield University£172,200
Cell Therapy Catapult Limited£153,505
Scottish National Blood Transfusion Service£109,452
RFID to enable ATMP Manufacturing, Cryogenic Supply Chain Scale-Up and Productivity GainsISCF · Collaborative R&D · 2018-09-30 – 2022-03-30 · with 4 other participants£1,088,922whole project
RFID to enable ATMP Manufacturing, Cryogenic Supply Chain Scale-Up and Productivity Gains
ISCF · Collaborative R&D · 2018-09-30 – 2022-03-30 · with 4 other participants
£1,088,922
whole project
Cryogatt Systems LimitedleadCell Therapy Catapult LimitedCranfield UniversityScottish National Blood Transfusion ServiceThermo Electron Limited
ISCF Funding for Advanced Therapy Manufacturing Apprenticeships
ISCF · Centres · 2018-06-30 – 2021-04-29
£1,499,198
whole project
ISCF Funding for Advanced Therapy Manufacturing ApprenticeshipsLead
ISCF · Centres · 2018-06-30 – 2021-04-29
£1,499,198
whole project
ATTC CoordinationLead
ISCF · Centres · 2018-05-31 – 2022-03-30
£1,706,975
whole project
ATTC Coordination
ISCF · Centres · 2018-05-31 – 2022-03-30
£1,706,975
whole project
Establishing Commercial AAV Manufacturing in the UKInnovate UK · Collaborative R&D · 2018-04-01 – 2020-03-31 · with 1 other participant£610,493awarded
Establishing Commercial AAV Manufacturing in the UK
Innovate UK · Collaborative R&D · 2018-04-01 – 2020-03-31 · with 1 other participant
£610,493
awarded
Cell Therapy Catapult Limited£610,493
Cell And Gene Therapy Catapult Core Delivery ProgrammeLead
Innovate UK · Centres · 2018-04-01 – 2023-08-31
£87,639,000
awarded
Project LEWISInnovate UK · Collaborative R&D · 2018-03-01 – 2021-02-28 · with 1 other participant£1,721,795awarded
Project LEWIS
Innovate UK · Collaborative R&D · 2018-03-01 – 2021-02-28 · with 1 other participant
£1,721,795
awarded
Cell Therapy Catapult Limited£1,721,795
CellFlow - Chemical-Free Cell Isolation for Commercial-Scale Cell Therapy ManufacturingInnovate UK · Collaborative R&D · 2018-03-01 – 2020-08-31 · with 3 other participants£51,464awarded
CellFlow - Chemical-Free Cell Isolation for Commercial-Scale Cell Therapy Manufacturing
Innovate UK · Collaborative R&D · 2018-03-01 – 2020-08-31 · with 3 other participants
£51,464
awarded
University of Cambridge£207,480
Cell Therapy Catapult Limited£51,464
CellFlow - Chemical-Free Cell Isolation for Commercial-Scale Cell Therapy ManufacturingISCF · Collaborative R&D · 2018-03-01 – 2020-08-30 · with 3 other participants£706,346whole project
CellFlow - Chemical-Free Cell Isolation for Commercial-Scale Cell Therapy Manufacturing
ISCF · Collaborative R&D · 2018-03-01 – 2020-08-30 · with 3 other participants
£706,346
whole project
Cost-driven process redesign, automation and scale-out for commercial manufacture of REX-001 therapyISCF · Collaborative R&D · 2018-03-01 – 2021-03-30 · with 3 other participants£1,282,679whole project
Cost-driven process redesign, automation and scale-out for commercial manufacture of REX-001 therapy
ISCF · Collaborative R&D · 2018-03-01 – 2021-03-30 · with 3 other participants
£1,282,679
whole project
Cost-driven process redesign, automation and scale-out for commercial manufacture of REX-001 therapyInnovate UK · Collaborative R&D · 2018-03-01 – 2021-03-31 · with 3 other participants£529,124awarded
Cost-driven process redesign, automation and scale-out for commercial manufacture of REX-001 therapy
Innovate UK · Collaborative R&D · 2018-03-01 – 2021-03-31 · with 3 other participants
£529,124
awarded
Cell Therapy Catapult Limited£529,124
A closed automatic modular cell culture system for personalised autologous cell therapyInnovate UK · Collaborative R&D · 2018-02-01 – 2020-01-31 · with 1 other participant£154,400awarded
A closed automatic modular cell culture system for personalised autologous cell therapy
Innovate UK · Collaborative R&D · 2018-02-01 – 2020-01-31 · with 1 other participant
£154,400
awarded
Cell Therapy Catapult Limited£154,400
Multi-donor allogeneic human retinal progenitor cell therapy (hRPC) 4sightInnovate UK · Collaborative R&D · 2018-02-01 – 2020-04-30 · with 3 other participants£300,140awarded
Multi-donor allogeneic human retinal progenitor cell therapy (hRPC) 4sight
Innovate UK · Collaborative R&D · 2018-02-01 – 2020-04-30 · with 3 other participants
£300,140
awarded
Cell Therapy Catapult Limited£300,140
Multi-donor allogeneic human retinal progenitor cell therapy (hRPC) 4sightISCF · Collaborative R&D · 2018-02-01 – 2020-04-29 · with 3 other participants£1,530,973whole project
Multi-donor allogeneic human retinal progenitor cell therapy (hRPC) 4sight
ISCF · Collaborative R&D · 2018-02-01 – 2020-04-29 · with 3 other participants
£1,530,973
whole project
Reneuron LimitedleadCell Therapy Catapult LimitedRoslin Cell Therapies LimitedUniversity College London
Establishing Freeline Commercial Scale Viral Gene Therapy Manufacture for Fabry DiseaseInnovate UK · Collaborative R&D · 2017-12-01 – 2020-01-31 · with 1 other participant£600,012awarded
Establishing Freeline Commercial Scale Viral Gene Therapy Manufacture for Fabry Disease
Innovate UK · Collaborative R&D · 2017-12-01 – 2020-01-31 · with 1 other participant
£600,012
awarded
Cell Therapy Catapult Limited£600,012
Industrial Viral Vector Manufacturing Using Advanced Process Analytical TechnologiesInnovate UK · Collaborative R&D · 2017-12-01 – 2020-01-31 · with 3 other participants£514,180awarded
Industrial Viral Vector Manufacturing Using Advanced Process Analytical Technologies
Innovate UK · Collaborative R&D · 2017-12-01 – 2020-01-31 · with 3 other participants
£514,180
awarded
Cell Therapy Catapult Limited£514,180
Strategies to reduce barriers to the implementation of performance based pricing schemesLead
Innovate UK · Centres · 2017-08-01 – 2018-03-31
£162,220
awarded
Advanced monitoring of gene therapy manufactureLead
Innovate UK · Centres · 2017-08-01 – 2018-03-31
£97,300
awarded
Development and Delivery of a Cell and Gene Therapy Industrialisation Workshop Seminar SeriesLead
Innovate UK · Centres · 2017-08-01 – 2018-03-31
£119,000
awarded
Scaling up cell & gene therapy manufacture for commercial supply by integration of a needle-to-needle supply chain into the CGCT manufacturing centreLead
Innovate UK · Centres · 2017-08-01 – 2018-03-31
£626,355
awarded
Cellular Immunotherapies -Developing Assays for Assessing Characteristics of Effective TherapiesLead
Innovate UK · Centres · 2017-08-01 – 2018-03-31
£49,900
awarded
GMP transition support for viral vector manufactureLead
Innovate UK · Centres · 2017-08-01 – 2018-03-31
£361,220
awarded
Supply Chain Mapping for ATMP’sLead
Innovate UK · Centres · 2017-08-01 – 2018-03-31
£198,319
awarded
Application of the Ranger® Technology (Stratophase) to T-Cell Expansion in Stirred Tank ReactorsLead
Innovate UK · Centres · 2017-08-01 – 2018-03-31
£263,900
awarded
ISCF Funding for Phase 2 of the C> Catapult Manufacturing CentreLeadISCF · Centres · 2017-07-31 – 2019-10-31 · with 1 other participant£12,000,000whole project
ISCF Funding for Phase 2 of the C> Catapult Manufacturing CentreLead
ISCF · Centres · 2017-07-31 – 2019-10-31 · with 1 other participant
£12,000,000
whole project
Cell Therapy Catapult LtdleadAdvance On Grant For Catapult Projects
ISCF Funding for Phase 2 of the C> Catapult Manufacturing CentreISCF · Centres · 2017-07-31 – 2019-10-31 · with 1 other participant£12,000,000whole project
ISCF Funding for Phase 2 of the C> Catapult Manufacturing Centre
ISCF · Centres · 2017-07-31 – 2019-10-31 · with 1 other participant
£12,000,000
whole project
Cell Therapy Catapult LtdleadAdvance On Grant For Catapult Projects
Project SILKINInnovate UK · Collaborative R&D · 2017-07-01 – 2020-06-30 · with 1 other participant£1,249,744awarded
Project SILKIN
Innovate UK · Collaborative R&D · 2017-07-01 – 2020-06-30 · with 1 other participant
£1,249,744
awarded
Cell Therapy Catapult Limited£1,249,744
Cell2Sell: commercial scale next generation platform for allogeneic stem cell productionInnovate UK · Collaborative R&D · 2017-05-01 – 2018-10-31 · with 1 other participant£1,016,825awarded
Cell2Sell: commercial scale next generation platform for allogeneic stem cell production
Innovate UK · Collaborative R&D · 2017-05-01 – 2018-10-31 · with 1 other participant
£1,016,825
awarded
Cell Therapy Catapult Limited£1,016,825
Design, Transfer and Qualification of a Commercially-Scalable Manufacturing Process for CAR-T cellsInnovate UK · Collaborative R&D · 2017-05-01 – 2019-10-31 · with 2 other participants£811,653awarded
Design, Transfer and Qualification of a Commercially-Scalable Manufacturing Process for CAR-T cells
Innovate UK · Collaborative R&D · 2017-05-01 – 2019-10-31 · with 2 other participants
£811,653
awarded
Cell Therapy Catapult Additional Funding (non-Core) for Financial Year 2016117 (“the Works”)Lead
Innovate UK · Centres · 2016-11-01 – 2017-03-31
£1,100,000
awarded
RaSTA (Rapid Sterility Testing Approach)Innovate UK · Collaborative R&D · 2016-08-01 – 2019-01-31 · with 2 other participants£297,853awarded
RaSTA (Rapid Sterility Testing Approach)
Innovate UK · Collaborative R&D · 2016-08-01 – 2019-01-31 · with 2 other participants
£297,853
awarded
Cell Therapy Catapult Limited£297,853
Enhanced Vector Bioprocessing Technologies for Cell and Gene TherapiesInnovate UK · Collaborative R&D · 2016-07-01 – 2019-06-30 · with 1 other participant£606,297awarded
Enhanced Vector Bioprocessing Technologies for Cell and Gene Therapies
Innovate UK · Collaborative R&D · 2016-07-01 – 2019-06-30 · with 1 other participant
£606,297
awarded
Cell Therapy Catapult Limited£606,297
Stem cell-derived exosomes for regenerative medicineInnovate UK · Collaborative R&D · 2016-05-01 – 2019-07-31 · with 2 other participants£740,151awarded
Stem cell-derived exosomes for regenerative medicine
Innovate UK · Collaborative R&D · 2016-05-01 – 2019-07-31 · with 2 other participants
£740,151
awarded
Automation of Cell Therapy Cryostorage Processes and Future Manufacturing FacilitiesInnovate UK · Collaborative R&D · 2016-02-01 – 2017-04-30 · with 3 other participants£94,715awarded
Automation of Cell Therapy Cryostorage Processes and Future Manufacturing Facilities
Innovate UK · Collaborative R&D · 2016-02-01 – 2017-04-30 · with 3 other participants
£94,715
awarded
Cell Therapy Catapult Limited£94,715
Cranfield University£0
miFACTS: Microfluidic system for Flexible Automated Cell Transduction and SelectionInnovate UK · Collaborative R&D · 2015-10-01 – 2018-09-30 · with 2 other participants£712,358awarded
miFACTS: Microfluidic system for Flexible Automated Cell Transduction and Selection
Innovate UK · Collaborative R&D · 2015-10-01 – 2018-09-30 · with 2 other participants
£712,358
awarded
Cell Therapy Catapult Limited£712,358
Ex vivo expansion of cord blood and bone marrow stem cellsInnovate UK · Collaborative R&D · 2015-09-01 – 2019-02-28 · with 2 other participants£360,705awarded
Ex vivo expansion of cord blood and bone marrow stem cells
Innovate UK · Collaborative R&D · 2015-09-01 – 2019-02-28 · with 2 other participants
£360,705
awarded
Oxford University (Dept. Engineering Science)£398,543
Cell Therapy Catapult Limited£360,705
Novel Platform Technology for Scaled Down Process Development and Optimisation of Regenerative MedicinesInnovate UK · Collaborative R&D · 2015-06-01 – 2017-02-28 · with 1 other participant£176,206awarded
Novel Platform Technology for Scaled Down Process Development and Optimisation of Regenerative Medicines
Innovate UK · Collaborative R&D · 2015-06-01 – 2017-02-28 · with 1 other participant
£176,206
awarded
Cell Therapy Catapult Limited£176,206
Cell Bandage for Repair of Torn Meniscus – development of an improved product and a manufacturing process suitable for its effective commercialisationInnovate UK · Collaborative R&D · 2015-04-01 – 2018-11-30 · with 3 other participants£275,776awarded
Cell Bandage for Repair of Torn Meniscus – development of an improved product and a manufacturing process suitable for its effective commercialisation
Innovate UK · Collaborative R&D · 2015-04-01 – 2018-11-30 · with 3 other participants
£275,776
awarded
NHS Blood and Transplant (NHSBT)£404,667
Cell Therapy Catapult Limited£275,776
MultiStem for the Treatment of Acute Respiratory Distress SyndromeInnovate UK · Collaborative R&D · 2015-04-01 – 2018-03-31 · with 1 other participant£1,249,526awarded
MultiStem for the Treatment of Acute Respiratory Distress Syndrome
Innovate UK · Collaborative R&D · 2015-04-01 – 2018-03-31 · with 1 other participant
£1,249,526
awarded
Cell Therapy Catapult Limited£1,249,526
Cell Therapy Catapult Core Delivery ProgrammeLead
Innovate UK · Centres · 2015-01-01 – 2018-07-31
£70,860,000
awarded
Cell Therapy Catapult Core Delivery Programme
Innovate UK · Centres · 2015-01-01 – 2018-07-31
£6,500,000
awarded
Stem cell-based 3D tissue engineered organ for tracheal replacementInnovate UK · Collaborative R&D · 2014-05-01 – 2018-01-31 · with 2 other participants£567,700awarded
Stem cell-based 3D tissue engineered organ for tracheal replacement
Innovate UK · Collaborative R&D · 2014-05-01 – 2018-01-31 · with 2 other participants
£567,700
awarded
Cell Therapy Catapult Manufacturing CentreLead
Innovate UK · Centres · 2014-04-01 – 2018-07-31
£45,190,000
awarded
Cell Therapy Catapult Manufacturing Centre
Innovate UK · Centres · 2014-04-01 – 2018-07-31
£4,000,000
awarded
Cell Therapy Catapult – Property EstablishmentLeadInnovate UK · Centres · 2012-08-01 – 2018-07-31 · with 1 other participant£5,980,900awarded
Cell Therapy Catapult – Property EstablishmentLead
Innovate UK · Centres · 2012-08-01 – 2018-07-31 · with 1 other participant
£5,980,900
awarded
Cell Therapy Catapult Limitedlead£5,980,900
Advance On Grant For Catapult Projects£500,000
Cell Therapy CatapultLeadInnovate UK · Centres · 2012-05-01 – 2014-12-31 · with 1 other participant£23,726,804awarded
Cell Therapy CatapultLead
Innovate UK · Centres · 2012-05-01 – 2014-12-31 · with 1 other participant
£23,726,804
awarded
Cell Therapy Catapult Limitedlead£23,726,804
Advance On Grant For Catapult Projects£6,000,000
LEXR: On-Site and On-Demand Radiation Processing and Sterilisation for the Production of Affordable Advanced Therapeutic Medicinal Products (ATMPs)Innovate UK · Collaborative R&D · with 2 other participants
LEXR: On-Site and On-Demand Radiation Processing and Sterilisation for the Production of Affordable Advanced Therapeutic Medicinal Products (ATMPs)
Innovate UK · Collaborative R&D · with 2 other participants